VEE Stock Overview
Provides cloud-based software for the life sciences industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Veeva Systems Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$207.60 |
| 52 Week High | US$222.10 |
| 52 Week Low | US$157.15 |
| Beta | 0.81 |
| 11 Month Change | 6.33% |
| 3 Month Change | 16.11% |
| 1 Year Change | 29.51% |
| 33 Year Change | -17.88% |
| 5 Year Change | 52.26% |
| Change since IPO | 518.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| VEE | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -1.1% | -0.1% | -0.02% |
| 1Y | 29.5% | -32.5% | 8.2% |
Return vs Industry: VEE exceeded the German Healthcare Services industry which returned -32.5% over the past year.
Return vs Market: VEE exceeded the German Market which returned 8.2% over the past year.
Price Volatility
| VEE volatility | |
|---|---|
| VEE Average Weekly Movement | 5.3% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: VEE has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: VEE's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 7,172 | Peter Gassner | www.veeva.com |
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process.
Veeva Systems Inc. Fundamentals Summary
| VEE fundamental statistics | |
|---|---|
| Market cap | €33.68b |
| Earnings (TTM) | €590.84m |
| Revenue (TTM) | €2.47b |
57.0x
P/E Ratio13.6x
P/S RatioIs VEE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VEE income statement (TTM) | |
|---|---|
| Revenue | US$2.57b |
| Cost of Revenue | US$685.87m |
| Gross Profit | US$1.89b |
| Other Expenses | US$1.27b |
| Earnings | US$615.26m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 05, 2024
| Earnings per share (EPS) | 3.80 |
| Gross Margin | 73.35% |
| Net Profit Margin | 23.91% |
| Debt/Equity Ratio | 0% |
How did VEE perform over the long term?
See historical performance and comparison